Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

CareDx Q3 Adj EPS $(0.18) Beats $(0.39) Estimate, Sales $67.19M Beat $53.14M Estimate

Author: Benzinga Newsdesk | November 08, 2023 05:32pm
CareDx (NASDAQ:CDNA) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.39) by 53.85 percent. This is a 200 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $67.19 million which beat the analyst consensus estimate of $53.14 million by 26.44 percent. This is a 15.33 percent decrease over sales of $79.36 million the same period last year.

Posted In: CDNA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist